Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Assets (2021 - 2025)

Cytek Biosciences' Return on Assets history spans 5 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Assets fell 13.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, down 13.0%, while the annual FY2025 figure was 0.14%, 13.0% down from the prior year.
  • Return on Assets reached 0.14% in Q4 2025 per CTKB's latest filing, down from 0.03% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2021 to a low of 0.14% in Q4 2025.
  • Average Return on Assets over 5 years is 0.02%, with a median of 0.01% recorded in 2024.
  • The largest YoY upside for Return on Assets was 2bps in 2025 against a maximum downside of -13bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2021, then dropped by -26bps to 0.0% in 2022, then plummeted by -593bps to 0.02% in 2023, then skyrocketed by 49bps to 0.01% in 2024, then crashed by -1032bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Return on Assets are 0.14% (Q4 2025), 0.03% (Q3 2025), and 0.01% (Q2 2025).